Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | XBP1 | P17861 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 5/20 | 0.38 |
| ▸ | NR1H4 | Q96RI1 | 4/20 | 0.37 |
| ▸ | ELANE | P08246 | 4/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24405188 | 0.88 | ELANE (0.40) | ATML3MBTL1GAAXBP1NPSR1 | |
| SCHEMBL25068834 | 0.87 | ATM (0.53) | ATML3MBTL1GAAXBP1NPSR1 | |
| SCHEMBL14477140 | 0.84 | ESR1 (0.36) | ESR1ELANEPOLBESR2 | |
| SCHEMBL12058674 | 0.82 | ELANE (0.51) | ESR1ELANE | |
| SCHEMBL19558305 | 0.80 | ELANE (0.56) | ESR1ELANE | |
| SCHEMBL12058542 | 0.79 | CYP3A4 (0.54) | ESR1ELANEPOLBESR2 | |
| SCHEMBL24405004 | 0.79 | ELANE (0.40) | ATML3MBTL1GAAXBP1NPSR1 | |
| SCHEMBL25515127 | 0.78 | MAOB (0.42) | ELANEMAPT | |
| SCHEMBL15395815 | 0.78 | ESR1 (0.46) | ATML3MBTL1GAAXBP1NPSR1 | |
| SCHEMBL25068947 | 0.77 | ELANE (0.45) | GAAELANETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11681220-B2 | Resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-06-20 | — | — | US | disclosed |
| US-20230152693-A1 | CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20210255545-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11681220-B2 | Resist composition and method for producing resist pattern | RER1, POLR1A, REV1 | ATM 2738/4885L3MBTL1 1715/4885GAA 2054/4885 |
| US-20210255545-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | FGFR1, RER1, FGF1 | ATM 3407/4885L3MBTL1 1095/4885GAA 4858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.